The Integration of Precision Medicine and Cytotoxic Agents
The modernization of chemotherapy is characterized by a fundamental shift toward "biomarker-guided" dosing, where traditional cytotoxic agents are tailored to a patient's unique genetic profile. This precision approach allows oncologists to predict how a specific tumor will respond to drugs like fluorouracil or methotrexate, optimizing the treatment schedule to maximize efficacy while sparing...
0 Σχόλια 0 Μοιράστηκε 552 Views 0 Προεπισκόπηση